280 related articles for article (PubMed ID: 22801395)
1. New oral anticoagulant in atrial fibrillation: are they comparable?
Kalodiki E; Lewis B; Fareed J
Int Angiol; 2012 Aug; 31(4):307-9. PubMed ID: 22801395
[No Abstract] [Full Text] [Related]
2. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
3. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Schneeweiss S; Gagne JJ; Patrick AR; Choudhry NK; Avorn J
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):480-6. PubMed ID: 22787066
[TBL] [Abstract][Full Text] [Related]
5. Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.
Skjøth F; Larsen TB; Rasmussen LH
Thromb Haemost; 2012 Sep; 108(3):405-6. PubMed ID: 22782445
[No Abstract] [Full Text] [Related]
6. [Improvements in oral anticoagulant therapy for atrial fibrillation].
Briongos Figuero S; García Santos-Gallego C; Badimón JJ
Med Clin (Barc); 2013 Dec; 141(11):487-93. PubMed ID: 23597953
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?
Harenberg J; Marx S; Wehling M
Thromb Haemost; 2012 Sep; 108(3):407-9. PubMed ID: 22837027
[No Abstract] [Full Text] [Related]
8. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
[TBL] [Abstract][Full Text] [Related]
9. [Differential therapy with the new anticoagulants, 5].
Stiefelhagen P
MMW Fortschr Med; 2013 May; 155(9):20. PubMed ID: 23951642
[No Abstract] [Full Text] [Related]
10. [New anticoagulants in patients with atrial fibrillation].
Diener HC; Weber R
MMW Fortschr Med; 2013 May; 155(8):55-6, 58. PubMed ID: 24437140
[No Abstract] [Full Text] [Related]
11. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
Aguilar MI; Kuo RS; Freeman WD
Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
[TBL] [Abstract][Full Text] [Related]
12. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Ahrens I; Lip GY; Peter K
Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
[No Abstract] [Full Text] [Related]
13. [Structured care for patients with new oral anticoagulants. Nursing based care of adults with atrial fibrillation].
Al-Khalili F; Lindström C
Lakartidningen; 2014 Oct 1-7; 111(40):1720-2. PubMed ID: 25759883
[No Abstract] [Full Text] [Related]
14. {blacktriangledown} Apixaban and {blacktriangledown} rivaroxaban for stroke prevention in AF.
Drug Ther Bull; 2014 Jan; 52(1):6-9. PubMed ID: 24401533
[TBL] [Abstract][Full Text] [Related]
15. Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.
Stöllberger C; Finsterer J
J Neurol; 2012 Jan; 259(1):168-9. PubMed ID: 22124666
[No Abstract] [Full Text] [Related]
16. [New anticoagulants: better knowledge, better prescriptions].
Boehlen F; de Moerloose P
Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817
[TBL] [Abstract][Full Text] [Related]
17. Defining non-valvular atrial fibrillation while selecting anticoagulation therapy.
Garg P; Ripley DP
Br J Hosp Med (Lond); 2015 Feb; 76(2):66-7. PubMed ID: 25671468
[No Abstract] [Full Text] [Related]
18. [Stroke risk--atrial fibrillation].
Dabitz R; Ochs G
MMW Fortschr Med; 2012 Nov; 154(19):53-6. PubMed ID: 23173288
[No Abstract] [Full Text] [Related]
19. Novel anticoagulants eliminate the need for left atrial appendage exclusion devices.
Ezekowitz MD; Kent AP
Circulation; 2014 Oct; 130(17):1505-14. PubMed ID: 25332278
[No Abstract] [Full Text] [Related]
20. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
Páramo JA
Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
